Shivering after spinal anesthesia. --
Conditions
Interventions
Intervention 1: Intratechal injection of 0.2 mg/kg pethidine plus lidocaine. Intervention 2: intratechal injection of lidocaine 100 mg two cc. Intervention 3: intratechal injection of 0.3 mg/kg of pet
Prevention
Intratechal injection of 0.2 mg/kg pethidine plus lidocaine
intratechal injection of lidocaine 100 mg two cc
intratechal injection of 0.3 mg/kg of pethidine plus lidocaine
Intratechal injection of 0.4 mg/kg pethidine plus lidocaine
Sponsors
Research committee of medical science
Eligibility
Sex/Gender
Female
Age
15 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: All women age between 15 and 50 who are candidates for caesarean section and signed informed consent are eligible to join the study. Exclusion criteria: any contra indication for R/A and those who are sensitive to opioid
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Post spinal shivering. Timepoint: 90 minute. Method of measurement: observation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Post operative nausea and vomiting. Timepoint: 90 minute. Method of measurement: observation.;Hemodynamic change (BP Change). Timepoint: 90 minute. Method of measurement: NIBP monitoring.;Core temperature change. Timepoint: 90 minute. Method of measurement: core temperature monitoring.;Apgar score of neonate. Timepoint: In minute 5 and 10. Method of measurement: Observation. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed